Boston Common Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.28M | Sell |
|
|||||
|
2025
Q2 | $4.85M | Sell |
|
|||||
|
2025
Q1 | $5.27M | Buy |
|
|||||
|
2024
Q4 | $3.61M | Sell |
|
|||||
|
2024
Q3 | $4.91M | Sell |
|
|||||
|
2024
Q2 | $5.17M | Sell |
|
|||||
|
2024
Q1 | $4.66M | Buy |
|
|||||
|
2023
Q4 | $4.55M | Sell |
|
|||||
|
2023
Q3 | $4.99M | Sell |
|
|||||
|
2023
Q2 | $5.42M | Buy |
|
|||||
|
2023
Q1 | $5.12M | Buy |
|
|||||
|
2022
Q4 | $4.5M | Buy |
|
|||||
|
2022
Q3 | $2.91M | Buy |
|
|||||
|
2022
Q2 | $2.55M | Buy |
|